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ttp://dx.doi.org/10.1016/j.ajpath.2014.09.013Pericytes are perivascular cells localized to capillaries that promote vessel maturation, and their
absence can contribute to vessel loss. Whether impaired endothelialepericyte interaction contributes
to small vessel loss in pulmonary arterial hypertension (PAH) is unclear. Using 3G5-speciﬁc, immu-
noglobulin Gecoated magnetic beads, we isolated pericytes from the lungs of healthy subjects and PAH
patients, followed by lineage validation. PAH pericytes seeded with healthy pulmonary microvascular
endothelial cells failed to associate with endothelial tubes, resulting in smaller vascular networks
compared to those with healthy pericytes. After the demonstration of abnormal polarization toward
endothelium via live-imaging and wound-healing studies, we screened PAH pericytes for abnormalities
in the Wnt/planar cell polarity (PCP) pathway, which has been shown to regulate cell motility and
polarity in the pulmonary vasculature. PAH pericytes had reduced expression of frizzled 7 (Fzd7) and
cdc42, genes crucial for Wnt/PCP activation. With simultaneous knockdown of Fzd7 and cdc42 in
healthy pericytes in vitro and in a murine model of angiogenesis, motility and polarization toward
pulmonary microvascular endothelial cells were reduced, whereas with restoration of both genes in PAH
pericytes, endothelialepericyte association was improved, with larger vascular networks. These studies
suggest that the motility and polarity of pericytes during pulmonary angiogenesis are regulated by Wnt/
PCP activation, which can be targeted to prevent vessel loss in PAH. (Am J Pathol 2015, 185: 69e84;
http://dx.doi.org/10.1016/j.ajpath.2014.09.013)Supported by postdoctoral fellowships from the American Heart As-
sociation (13POST17120040 to K.Y.), the Stanford Translational
Research Seed Grant School of Medicine (K.Y.), NIH grant K08
HL105884-01, a Harold Amos Career Development Award, an American
Lung Association Biomedical Research Award, the Stanford Translational
Research and Applied Medicine Program, and the Stanford Cardiovas-
cular Institute (V.A.d.J.P.).
Disclosures: None declared.Pericytes are highly specialized vascular cells that directly
interact with endothelial cells (ECs) to provide mural sup-
port and to help promote small vessel maturation and
survival.1e3 The deﬁnition of a mature pericyte is very
controversial, but the currently accepted deﬁnition describes
cells embedded within the vascular basement membrane of
blood microvessels making speciﬁc focal contacts with
endothelium, that is, capillaries, postcapillary venules, and
terminal arterioles.3 Pericytes closely interact with ECs
through both paracrine and juxtacrine mechanisms.4 Loss or
dysfunction of pericytes is involved in multiple pathologies,
such as Alzheimer disease, hypertension, diabetic retinop-
athy, and tumor angiogenesis.5e8 To date, most studies have
centered on elucidating the contribution of pericytes tostigative Pathology.
.systemic microvessel, but very little is known about their
role in the pulmonary circulation.
Lung pericytes can be found at the level of small pre-
capillary arteries (<30 mm), capillaries (approximately 10
mm) and postcapillary venules, where they provide mural
support and regulate vasomotor tone.9 Whereas larger
Yuan et al(>50 mm) pulmonary arteries (PA) are fully enveloped by
multiple layers of smooth muscle cells (PASMCs), pre-
capillary arteries are only partially enveloped by peri-
cytes.9 This structural arrangement is important for lung
function as the pulmonary circulation is designed to be a
low-pressure, high-compliance system capable of accom-
modating the entire cardiac output for optimal oxygena-
tion and rapid delivery to the left ventricle for systemic
distribution. However, when these precapillary arteries
become muscularized, pulmonary vascular resistance and
impedance increase, resulting in pulmonary arterial hy-
pertension (PAH), a life-threatening disorder associated
with a progressive rise in pulmonary pressures resulting
from: i) loss of and/or impaired regeneration of small
peripheral pulmonary arteries, ii) occlusion of larger
proximal pulmonary arteries due to uncontrolled prolif-
eration of smooth muscle cells, and iii) deposition of
extracellular matrix.10 Efforts to elucidate the mechanisms
related to small vessel loss in PAH have centered mostly
on pulmonary ECs, but little is known about the contri-
bution of pulmonary pericytes to PAH pathobiology.
Recently, a study looked at pericyte distribution in the
pulmonary circulation of PAH patients and reported
increased pericyte numbers in close proximity to pulmo-
nary microvessels, along with a pro-proliferative and
promigratory phenotype when the cells were puriﬁed and
cultured in vitro.11 Although these observations seem to
support a potential contribution of these cells to PAH
pathology, it is still unclear whether the ability of peri-
cytes to establish functional cellecell contacts with ECs in
pulmonary microvessels is also adversely affected in
PAH. Given the role of pericytes in promoting the growth
and maturation of microvessels, we predicted that failure
of pericytes to associate with ECs in PAH could contribute
to small vessel loss by preventing proper vascular growth,
structural stability, and survival.
Here, we demonstrate for the ﬁrst time that PAH pericytes
puriﬁed from the lung of PAH patients using a unique re-
combinant antie3G5-immunoglobulin (Ig)G failed to
properly associate with endothelial tubes in vitro, resulting
in smaller vascular networks and thinner endothelial tubes.
We show that this is due to an intrinsic defect in cell motility
and polarization that impairs the ability of PAH pericytes to
migrate toward the vascular tubes, resulting in a signiﬁ-
cantly lower number of endothelial-pericyte interactions.
We further show that these defects correlate with reduced
activity of the Wnt/planar cell polarity (PCP), a pathway
known to be crucial for the control for cell motility and
polarity, resulting from reduced expression of frizzled 7
(Fzd7) and cdc42, key components of this signaling
pathway. Taken together, our study provides the ﬁrst evi-
dence that PAH pericytes contribute to small vessel loss in
PAH and that therapeutic strategies capable of restoring
Wnt/PCP activity in these cells could help to prevent loss
and/or facilitate small vessel regeneration in patients
afﬂicted with this devastating disease.70Materials and Methods
Cell Culture
Control pulmonary microvascular ECs (PMVECs; Promo-
Kine catalog number C-12282; PromoCell GmbH, Heidel-
berg, Germany) were grown in EC media (PromoKine
catalog number C-22120; PromoCell GmbH) with growth
supplements and used between passages 4 to 8.Generation of 3G5 IgG1 Antibody
3G5 (ATCC CRL-1814) hybridoma cells were cultured in 1
Dulbecco’s modiﬁed Eagle’s medium with 10% fetal bovine
serum (FBS). Culture medium was collected and concentrated
by centrifugal ﬁlter Amicon Ultra-15 (Millipore Corporation,
Billerica, MA). The 3G5 IgM was isolated using the IgM
Puriﬁcation Kit (Pierce Biotechnology, Inc., Rockford, IL),
and its concentration was later determined by the Lowry
method. IgM isotype switch to mouse IgG was performed and
validated by LakePharma LLC (San Carlos, CA). Brieﬂy,
variable regions of 3G5 IgM antibody heavy and light chains
were sequenced. Then, cDNAs of IgM heavy and light chains
were constructed and cloned into pcDNA3 containing murine
IgG light and heavy chain constant regions, respectively. Both
plasmids were simultaneously transfected into HEK293 cells,
which produced and released the recombinant 3G5 IgG anti-
body into the medium. The 3G5 IgG antibody was then pu-
riﬁed using a commercial IgG puriﬁcation kit.Pericyte Isolation and Culture
Lung tissues from PAH and control patients were provided by
the Pulmonary Hypertension Breakthrough Initiative, which is
funded by the Cardiovascular Medical Research And Educa-
tionFund.The day before the pericyte isolation, 40mLofM280
sheep anti-mouse IgG Dynabeads (11201D; Invitrogen Life
Technologies Corporation, Carlsbad, CA)were incubatedwith
10 mg of 3G5 IgG overnight. The next day, fresh lung tissue
was washed with 1 Hanks’ balanced salt solution twice to
remove medium. Then, tissue was minced and digested in a
solution containing collagenase (Sigma-Aldrich, St. Louis,
MO), dispase, and DNase I for 15 to 30 minutes at 37C on an
orbital shaker. An equivalent amount of cold pericyte medium
(ScienCell Research Laboratories, Carlsbad, CA) containing
2% FBS was added immediately after digestion. The suspen-
sion was passed through a BD Falcon 100-mmmesh ﬁlter (BD
Biosciences, San Jose, CA) to remove debris or undigested
ﬁbrous tissue. The cell pellet was resuspended in 1mL1 PBS
containing 0.2%FBS and 40 mL of 3G5 IgGecoatedmagnetic
beads andgently rotated at 4Cfor 45minutes.Beadswere then
washed ﬁve times with 1 PBS and seeded in gelatin-coated
cell-culture plates with pericyte medium. Fresh medium was
replaced every other day to promote pericyte attachment and
propagation, which occurred after days 5 to 7. The clinical andajp.amjpathol.org - The American Journal of Pathology
ECePC Interactions in Lung Angiogenesishemodynamic data fromhealthy donors and PAHpatientswho
served as the sources of the pericytes are listed in Table 1.
Fluorescence-Activated Cell Sorting
Pericytes within passages 4 to 5 collected as described in
Pericyte Isolation and Culture were serially propagated in
complete pericyte media on gelatin-coated tissue culture plates
for ﬂuorescence-activated cell sorting. Immunophenotyping of
cell surface molecules was performed by labeling cells with
directly conjugated antibodies: NG-2-PE (FAB2585P; R&D
Systems Inc.,Minneapolis,MN), thymus cell antigen 1 (catalog
number 562685; BD Biosciences), CD146-PE-Cy7 (catalog
number 562135; BD Biosciences), platelet-derived growth
factor receptor (PDGFR) bPerCPC Y5.5 (catalog number
562714; BD Biosciences), CD31 PerCP-eFlow 710 (catalog
number 46-0319-41; eBioscience, Inc., SanDiego,CA),CD45-
APCCY7 (catalog number 47-0459-41; eBioscience, Inc.), and
3G5 IgG. For assessing intracellular protein expression, cells
wereﬁxed and permeabilizedwith Cytoﬁx/Cytoperm Plus (BD
Biosciences) and incubated with the primary antibodies: a-
smooth muscle actin (SMA)eﬂuorescein isothiocyanateTable 1 Clinical Characteristics of Patient Samples
Patient
type
Patient
no.
Age,
years Sex Etiology
PAH 1 35 M APAH-congenital systemic to
pulmonary shunt-ASD
2 37 M FPAH
3 53 F APAH-collagen vascular disease/
systemic lupus erythematous
4 54 F APAH-scleroderma
5 13 F APAH-congenital (s/p PDA ligation
6 14 F IPAH
7 42 F APAH-drugs and toxins-amphetam
8 7 F IPAH
9 28 M IPAH
Failed Donor 1 26 M Gunshot wound to the head
2 36 F Subarachnoid hemorrhage
3 25 M Cerebrovascular/stroke, intracrania
hemorrhage
4 26 M Drug intoxication/anoxia
5 60 F Intracranial hemorrhage
6 30 M Head trauma due to MVC
7 34 F NA
8 49 F Intracranial hemorrhage
9 57 F Anoxia
F, female; M, male; 6MWD, 6-minute walking distance; APAH, associated pulmon
arterial hypertension; IPAH, idiopathic pulmonary arterial hypertension; mPAP, me
PDA, patent ductus arteriosus; PVR, pulmonary vascular resistance; WU, Wood un
The American Journal of Pathology - ajp.amjpathol.org(ab8211; Abcam plc, Cambridge, UK), calponin (ab700;
Abcam plc), smooth muscle 22-a (SM22a; ab10135; Abcam
plc), and smooth muscle myosin heavy chain (IC4470A; R&D
Systems Inc.). At least 10,000 events were acquired for each
sample onLSR II (BDBiosciences) and analyzed using FlowJo
(Tree Star Inc., Ashland, OR). ECs, human brain pericytes
(number 1200; ScienCell Research Laboratories), pulmonary
arterial smoothmuscle cells (number 3110; ScienCell Research
Laboratories), and human blood mononuclear cells from buffy
coat were analyzed in parallel as positive controls. Isotype
controls were used as negative controls.
Immunoﬂuorescence Staining
Around 1  104 cells were seeded on four-well EZ slides
(Millipore Corporation) on the day before the staining.
Next, cells were ﬁxed for 15 minutes in 4% para-
formaldehyde, followed by three washes with PBS. Cells
were then permeabilized with ice-cold 1 PBS containing
0.1% Triton X-100 and goat serum for 1 hour, followed by
overnight incubation with primary antibodies at 4C,
washed in 1 PBS, and incubated with Alexa Fluor 5946MWD
(m) Therapies
Hemodynamics
mPAP,
mm Hg
PVR,
WU
430 Sildenafil, bosentan 75 NA
309 Sildenafil, sitaxsentan,
ambrisentan, epoprostenol,
imatinib
77 14.22
400 Sildenafil, tadalafil, ambrisentan 58 19.34
419 Sildenafil, ambrisentan,
epoprostenol
NA 8.23
) 166 Sildenafil, bosentan, treprostinil 100 39
440 Tadalafil, ambrisentan,
treprostinil
86 NA
ine NA Tadalafil, ambrisentan,
treprostinil
52 NA
422.5 Sildenafil, ambrisentan,
bosentan, iloprost, treprostinil
88 17.62
166.1 NA 77 NA
l
ary arterial hypertension; ASD, atrial septal defect; FPAH, familial pulmonary
an pulmonary arterial pressure; MVC, motor vehicle crash; NA, not available;
its.
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Yuan et algoat anti-mouse antibody and/or Alexa Fluor 488 goat anti-
rabbit (A11008; Invitrogen) accordingly for 1 hour at room
temperature. Slides were mounted with Prolong Gold anti-
fade solution containing DAPI (Invitrogen).
Matrigel Co-Culture Tube-Formation Assay
Matrigel (Basement Membrane Extract, Trevigen, Gaithers-
burg, MD) was thawed on ice overnight and dispersed on 96-
well plates (55 mL per plate) and allowed to polymerize for 30
minutes at 37C. PMVECs and pericytes were stained with the
cell membrane dyes PKH67 (MINI67; Sigma-Aldrich) and
PKH26 (MINI26; Sigma-Aldrich), respectively, following the
manufacturer’s protocol. Around 5000 PMVECs were mixed
with 1000 pericytes in 100 mL 2% FBS pericyte medium and
then loaded on eachMatrigel-coatedwell. After 4 hours, images
were obtained and assessed by using a DMRB II ﬂuorescence
microscope (Leica Microsystems Inc., Buffalo Grove, IL).
Total numbers of tubes, branching points, and loops were
quantiﬁed using Wimasis software (Wimasis GmbH, Munich,
Germany). Mean values for pericyte coverage of endothelial
tubes were obtained from three independent experiments.
Boyden Chamber Assay
Before the experiment, cells were synchronized in starvation
media (0.1% FBS in pericyte media) for 48 hours. To
evaluate cell migration, single-cell suspensions of 2  104
cells were plated in triplicate into 24-well, 8 mmepore
invasion chambers (3097; Becton, Dickinson, and Com-
pany, Franklin Lakes, NJ) according to the manufacturer’s
instructions. Translocated cells were quantiﬁed after 6 hours
by hematoxylin and eosin staining. The mean number of
cells in four 20 random ﬁelds was used for analysis.
Wound-Healing Co-Culture Assay
Cell-culture plates with inserts (catalog number 81176) were
purchased from ibidi GmbH (Munich, Germany). Around
1.5 104 cells (PMVECs and pericytes) were seeded into either
side of the inserts. Cells were synchronized using starvation
media for 16 hours before removal of the inserts. Serial images
of the gap between PMVECs and pericytes were taken over
a period of 6 hours. Cell migration rate and orientation were
calculated by comparing cells at 0 and 6 hours. Pericentrin
(1:1000; ab4448; Abcam plc) and phalloidin-labeled F-actin
(1:50; Invitrogen) were used to stain the microtubule-
organizing center (MTOC) and actin ﬁlaments, respectively.
TaqMan Quantitative PCR
Quantitation of mRNA expression was determined by real-
time quantitative RT-PCR (Applied Biosystems Inc., Foster
City, CA) following the manufacturer’s protocol. Brieﬂy, 25
ng of mRNA (RNeasy Mini Kit, Qiagen, Germantown, MD)
was used for each reaction. The PCR reaction mixture was72denatured at 95C for 15 minutes and then run for 40 cycles
(94C for 15 seconds, 55C for 30 seconds, and 70C for 30
seconds). Melting curve analysis was run at the same time to
rule out nonspeciﬁc reactions or contamination. Glyceral-
dehyde-3-phosphate dehydrogenase was used for normali-
zation. Agarose gel electrophoresis, using 1% gels, was used
for veriﬁcation of uncertain results. All quantitative PCR was
run in triplicate. The difference in mRNA expression was
determined by DDCT. The reverse-transcription kit was
purchased from Fermentas (Vilnius, Lithuania) and TaqMan
PCR primer sets were purchased from Life Technologies.
Western Immunoblot Analysis
Cellswerewashed three timeswith ice-cold 1 PBS, and lysates
were prepared by adding boiling lysis buffer (1 radio-
immunoprecipitation assay buffer and 1 mmol/L phenyl-
methylsulfonylﬂuoride), scraping into a 1.5-mLmicrocentrifuge
tube, and boiling for 10 minutes before centrifugation. Super-
natants were transferred to fresh microcentrifuge tubes and
stored at 80C. The protein concentration was determined by
the Lowry assay (Bio-Rad Laboratories S.r.l., Segrate, Italy).
Equal amounts of protein were loaded onto each lane of a 4% to
12%Bis- Tris gel (Life TechnologiesCorporation) and subjected
to SDS-PAGE electrophoresis under reducing conditions. After
blot analysis, polyvinylidene diﬂuoride membranes were
blocked for 1 hour in blocking buffer (5% milk powder in 0.1%
PBS/Tween20) and incubated with primary antibodies for Fzd7
(ab64636; Abcam plc) and cdc42 (07-1466; Millipore Corpo-
ration) overnight at 4C. Horseradish peroxidase conjugated
secondary antibodies were visualized by Amersham ECL (GE
Healthcare Bio-Sciences, Pittsburgh, PA). Signal normalization
was performed with a mouse monoclonal antibody against a-
tubulin (Sigma-Aldrich).
RNA Interference
To achieve gene knockdown, 2mmol/L siRNAof Fzd7 (catalog
number M-003671-02-0005; Thermo Fisher Scientiﬁc Inc.,
Rockford, IL) and/or 2 mmol/L siRNA of cdc42 (catalog
number M-005057-01-0005; Thermo Fisher Scientiﬁc Inc.) or
nontargeting siRNA control (catalog number D-001810-10-05;
Thermo Fisher Scientiﬁc Inc.) was transfected into healthy
pericytes. Knockdown efﬁciency was evaluated 72 hours after
electroporation by measuring Fzd7 or total cdc42 protein levels
in cell lysates via Western immunoblot analysis. Transfection
was performed using an Amaxa Nucleofector II (program
U-25) with the Basic Smooth Muscle Cell Nucleofector kit
(Lonza, Basel, Switzerland). All Matrigel or wound-healing
experiments were performed 72 hours after electroporation.
Plasmids
PAH pericytes were co-transfected with 1 mg of pCMV6-
AC-Fzd7-GFP (RG204167; OriGene Technologies, Inc.,
Rockville, MD) and 1 mg of pCMV6-AC-cdc42-GFPajp.amjpathol.org - The American Journal of Pathology
ECePC Interactions in Lung Angiogenesis(RG214076; OriGene Technologies, Inc.) in a transfection
device (Nucleofector II Program U-052; Lonza) using the
basic SMC Nucleofector kit (Lonza). The empty pCMV6-
AC-GFP vector (PS100010; OriGene Technologies, Inc.)
served as a negative control. Cells were incubated with 200
mg/mL neomycin for antibiotic selection and were plated in
Matrigel 48 hours later.
Active RhoA/Rac1/cdc42 Pull-Down Assays
Pericytes were cultured in pericytes medium (number 1201;
ScienCell Research Laboratories) and in a 100-mm Petri
dish until 80% conﬂuence was reached. After cells were
starved by 0.2% FBS medium for 24 hours, they were
washed three times with ice-cold 1 PBS. Cell lysates were
prepared by adding 500 mL of ice-cold magnesium lysis
buffer (10 mmol/L Tris-HCl, 1.0% SDS, 0.2 mmol/L phe-
nylmethylsulfonyl ﬂuoride, and protease and phosphatase
inhibitor cocktails I and II; Millipore Corporation) to the
cells and scraping into a 1.5-mL microcentrifuge tube on ice
before cold centrifugation at 14,000  g for 10 minutes.
Supernatants were transferred to fresh microcentrifuge tubes
and stored at 80C. Active forms of Rho protein A
(RhoA) or Ras-related C3 botulinum toxin substrate 1
(Rac1) were precipitated using glutathione beads containing
rhotekin or p21-activated kinase 1, respectively, according
to the manufacturer’s protocol (Millipore Corporation). In
brief, lysates were incubated with slurry containing the
glutathione beads for 1 hour at 4C with constant rotation.
At the end of this period, beads were precipitated by
centrifuging lysates at 14,000  g for 20 seconds. After
washing three times with ice-cold buffer, beads were
resuspended in Laemmli buffer, boiled, and subjected to
Western immunoblot analysis.
Matrigel Plug Angiogenesis Assay in SCID Mice
Animal experiments were approved by Stanford University’s
institutional review board and followed the guidelines of the
American Physiological Society. Matrigel plugs containing
PMVECs alone or with pericytes were prepared as described
previously.12 Brieﬂy, 48 hours after siRNA transfection,
2 105 pericytes with 1.0 106 PMVECs were suspended in
chilled 500 mL/plug of Matrigel growth factorereduced solu-
tion (BD Biosciences), to which 50 mg/mL ﬁbroblast growth
factor (FGF) (100-18B; PeproTech Inc., Rocky Hill, NJ) was
added. Plugs were implanted in the backs of severe combined
immunodeﬁciency (SCID) mice (Charles River Laboratories
International, Inc., Wilmington, MA) anesthetized by s.c. in-
jection of ketamine/xylazine. For each experimental condition,
a total of two plugs were implanted in each animal and allowed
to remain in place for 14 days. At the end of this period, the
animals were humanely sacriﬁced, and the Matrigel plugs were
removed and ﬁxed in 4% paraformaldehyde for 24 hours before
parafﬁn embedding. Unstained tissue samples were double-
labeled with Alexa Fluor 488elabeled anti-human CD31The American Journal of Pathology - ajp.amjpathol.org(LS-B4737, LifeSpan Biosciences, Inc., Seattle, WA) and
Alexa Fluor 555elabeled anti-mouse CD31 (catalog number
553370, BD Biosciences) to identify human or murine ECs,
Cy3-a-SMA (C6198; Sigma-Aldrich) to identify pericytes, and
DAPI for nuclear staining. Ten images per slide were captured
using the 40 objective of DMRB II ﬂuorescence inverted
microscope and analyzed using LAS X software version 1.1.0
(Leica Microsystems Inc.). The presence of microvessels
(deﬁned as tubes ﬁlled with red blood cells) was documented
using hematoxylin and eosin section, and the numbers of
human and murine cells and pericytes per condition were
quantiﬁed using the aforementioned immunoﬂuorescence
techniques.
Live-Imaging Video Microscopy
Cells were allowed to attach and spread on glass coverslips in
the incubator and were viewed on an inverted microscope
(DMRB II; Leica Microsystems, Inc.). The microscope is also
equipped with a heated stage, differential interference contrast
optics, and epiﬂuorescence. Filters and light paths were
controlled with a ﬁlter wheel and shutters (Ludl Electronic
Products Ltd., Hawthorne, NY). For green and red ﬂuorescent
protein visualization, a single-band excitation ﬁlter for ﬂuo-
rescein isothiocyanate and Texas Red, respectively, were used.
Tissue culture medium without phenol red was kept warm and
buffered in a CO2 incubator. The stage temperature was kept at
37C with an automatic thermostat. Images were collected
using a charge-coupled device camera (C2400; black and
white) with on-chip integration and a digital image processor
(Argus 20; PerkinElmer, Waltham, MA). Acquired images
were assembled in temporal sequences using Leica software
and saved as QuickTime videos (Apple, Inc., Cupertino, CA).
The path traveled by the cells was calculated by recording the
position of the nucleus in individual frames using ImageJ
software version 1.44p (NIH, Bethesda,MD) and plotting on an
xy axis followed by measurement of the distance between each
of the individual points.
Statistical Analysis
Values from multiple experiments are expressed as
means  SEM. Statistical signiﬁcance was determined using
either an unpaired t-test or one-way analysis of variance
followed by Bonferroni multiple comparison tests unless
stated otherwise. P < 0.05 was considered signiﬁcant.
Results
Isolation and Characterization of Pericytes from
Healthy Donor and PAH Lungs Using Recombinant 3G5
IgGeCoated Magnetic Beads
Previous studies have reported successful isolation of peri-
cytes from tissues such as skin13 and lungs11 using antie
3G5 IgM coupled magnetic beads. In our hands, this73
Yuan et almethod led to inconsistent pericyte yields per isolation,
likely due to IgM polymerization during storage. In an
effort to develop a more reliable and reproducible isolation
method, we sequenced the variable domains of the 3G5
IgM and cloned them into a murine IgG backbone fol-
lowed by magnetic bead coupling (Figure 1A). Compared
to 3G5 IgM, the yield of pericytes obtained using the 3G5
IgG was signiﬁcantly greater (>20%) and more consistent
per isolation. In culture, pulmonary pericytes extend74numerous cell processes when seeded in Matrigel while
displaying a smooth muscle cell (SMC)-like morphology
when attached to gelatin-coated plates (Figure 1A). To
validate pericyte lineage, we used ﬂuorescence-activated
cell-sorting analysis to document the expression of well-
known pericyte markers such as NG2, 3G5, CD90/
thymus cell antigen 1, CD146, PDGFRb, calponin,
a-SMA, and SM22a, as well as the absence of other
lineage markers such as CD31 and CD45, which areFigure 1 Puriﬁcation and characterization of lung pericytes using
3G5 IgGecoated magnetic beads. A: Method for pericyte puriﬁcation.
Representative micrographs of lung pericytes stained with calcein AM
are shown on Matrigel or on gelatin-coated cell-culture plates. B:
Fluorescence-activated cell sorting analysis of lung pericytes using
pericyte lineage markers. Red curves represent lung pericytes; blue,
positive controls (brain pericytes for pericyte markers CD90, NG2,
platelet derived growth factor receptor beta (PDGFRb), CD146, and 3G5,
calponin, and anti-smooth muscle actin (a-SMA); pulmonary artery
smooth muscle cells for smooth muscle myosin heavy chain (SMHHC),
pulmonary microvascular endothelial cells (PMVEC) for CD31, and pe-
ripheral blood mononuclear cells for CD45). C: Immunoﬂuorescence
studies of lung pericytes stained with NG2, calponin, PDGFRb, and
a-SMA. Note that no stain is seen with CD31 and SMMHC. D: Confocal
images of 3G5-stained lung sections. Endothelium is stained with CD31
(green); pericytes, with 3G5 IgG (red). Arrows indicate pericyte-
positive staining. DAPI labels cell nuclei (blue). Scale bars: 20 mm
(A); 10 mm (C); 50 mm (D).
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(Figure 1B). It is also worth noting that pericytes could be
distinguished from SMC by their lack of expression of
smooth muscle myosin heavy chain,14 a lineage marker
expressed mainly by differentiated SMC (Figure 1B).
Finally, the expression of the pericyte markers NG2,
calponin, PDGFRb, and a-SMA was further conﬁrmed
by immunoﬂuorescence in cultured lung pericytes
(Figure 1C). Finally, in agreement with previous reports,11
we found that 3G5 IgG labels mural cells adjacent to lung
capillaries (Figure 1D) in a manner comparable to that of
its IgM counterpart (data not shown).
Establishment of EndothelialePericyte Interactions by
PAH Pericytes Is Signiﬁcantly Reduced in a Matrigel
Co-Culture Model
Pericytes are known to provide mural support and promote
vessel stabilization. Whether PAH pericytes display an
abnormal phenotype in this regard is unknown. To test
this, we co-cultured healthy PMVECs with either healthy
donor or PAH pericytes at a 5:1 ratio in Matrigel, a bio-
logical matrix that promotes tube formation by ECs
in vitro.15 Compared to PMVECs alone (Figure 2A), co-
culture with healthy pericytes resulted in a threefold in-
crease in the size of the tube networks, as evidenced by the
total numbers of tubes, branching points, and loops
(P < 0.05) (Figure 2B). In contrast, co-culture of healthy
PMVECs with PAH pericytes under the same conditions
resulted in a vascular network that was no different in size
as that seen when PMVECs were cultured alone
(Figure 2C). To determine whether the observed difference
in network size was associated with a difference in pericyte
distribution, we stained pericytes with a red (PKH26) and
PMVECs with a green (PKH67) cell membrane dye (see
Materials and Methods) and visualized them in co-culture.
We found that healthy pericytes established contacts with
ECs mostly along the length of the vascular tubes
(Figure 2B), whereas PAH pericytes tended to cluster away
from the vascular tubes either within the nodes or outside
in the Matrigel (Figure 2C).
Based on our ﬁndings, we speculated whether a motility
defect could account for the abnormal PAH pericyte dis-
tribution seen in the Matrigel co-culture. To test this, we
used live-imaging video microscopy (LVM) to monitor the
behavior of PKH26-labeled pericytes and PKH67-labeled
PMVECs during the assembly of the vascular tube network.
As expected, healthy donor pericytes demonstrated vigorous
polarization and migration toward the developing endothe-
lial tubes that would culminate in pericyte association to the
outer layer of the tubes (Supplemental Figure S1A and
Supplemental Movie S1). In contrast, most PAH pericytes
failed to demonstrate either polarization and/or spontaneous
motility toward adjacent areas where endothelial tubes were
being formed (Supplemental Figure S1B and Supplemental
Movie S2).The American Journal of Pathology - ajp.amjpathol.orgPAH Pericytes Demonstrate Reduced Motility and Slow
Cytoskeletal Rearrangements
Cell motility is a complex behavior characterized by dy-
namic changes in cell shape made possible by active rear-
rangement of the cytoskeleton.16 To further delineate the
cell shape patterns of healthy donor and PAH pericytes
during spontaneous cell movement, we used LVM to
monitor pericyte monocultures over 4 hours and tracked
both the movement and cell shape changes occurring in both
healthy donor and PAH during that time period. Compared
to their healthy counterparts, PAH pericytes were signiﬁ-
cantly slower and traced shorter cell paths (Supplemental
Figure S1C). A closer look at cell morphology during this
time period revealed that healthy pericytes display active
exploratory behavior as demonstrated by the presence of
wide and dynamic lamellipodia at their front end and pro-
pulsive activity associated with contraction along the lon-
gitudinal cell axis (Supplemental Figure S1D and
Supplemental Movie S3). In contrast, PAH pericytes
demonstrated much narrower and less dynamic ﬁlopodia
and lamellipodia that connected to the main cell body via a
long cytoplasmic process, resulting in a much longer and
narrower body axis (Supplemental Figure S1D and
Supplemental Movie S4). Furthermore, these cells also
appeared to be less contractile and remained attached to a
given area longer, which could account for their limited
ability to cover the same distance as healthy donor cells.
PAH Pericytes Display Reduced Polarization toward
PMVEC Monolayers
To properly carry out its assigned role in angiogenesis, a
pericyte must be capable of migrating toward emerging
blood vessels. This event is triggered by secreted factors
(eg, PDGF, FGF) released by ECs, which help polarize the
pericyte toward the blood vessel.1,17 A key ﬁnding in our
LVM co-culture studies was the apparent lack of polariza-
tion of PAH pericytes toward the endothelial tubes, leading
us to investigate whether polarization was abnormal in these
cells. Using a modiﬁed Boyden chamber assay, we seeded
either healthy donor or PAH pericytes on top of the 8-mm
porous membrane followed by placement inside a 24-well
plate containing healthy PMVECs (Figure 2E). In the
absence of PMVECs, healthy donor pericytes spontaneously
transmigrated in signiﬁcantly greater numbers compared to
PAH cells, a phenomenon that was signiﬁcantly enhanced
when the pericytes were co-cultured with PMVECs
(Figure 2E).
Although the Boyden chamber assay is designed to test
chemotaxis in response to a stimulus (eg, PMVEC derived
growth factors), it does not provide information concerning
cytoskeletal rearrangements required to ensure polarization
toward the source of the stimulus. To complement our
Boyden chamber studies, we also performed wound-healing
studies designed to assist us in measuring pericyte polarity75
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ECePC Interactions in Lung Angiogenesisin response to PMVECs. Using a wound-healing assay
optimized to allow co-culture of PMVECs and pericytes
(Figure 2F), we measured the degree of cell polarization by
staining pericytes for pericentrin, a protein located within
the MTOC. During cell motility, the MTOC is localized to
the front of the nucleus and aligns itself with the long axis of
the cells, thus helping to identify the direction of cell
movement.18 After 6 hours, we saw that the MTOC of most
healthy pericytes close to the wound edge pointed toward
the PMVECs in the opposite side, and that the pericytes
initiated movement in that direction, as evidenced by nar-
rowing of the wound gap during this time (Figure 2G). In
contrast, PAH pericytes demonstrated a threefold more
random MTOC orientation along the length of the wound
edge, which correlated with a fourfold decrease in wound
gap narrowing after 6 hours of culture (Figure 2, G and H).The Wnt/PCP Pathway Is a Candidate Pathway that
Regulates Pericyte Motility and Polarity during
Angiogenesis
As our next step, we sought to investigate the mechanisms
that regulate pericyte motility and polarization, with the goal
of identifying possible genetic abnormalities that contribute
to the observed abnormal phenotype of PAH pericytes. Using
co-culture studies similar to ours, investigators have identi-
ﬁed key roles for multiple signaling pathways in promoting
pericyte recruitment to ECs during angiogenesis. At present,
it is thought that growth factors released by ECs trigger
signaling pathways within pericytes that ultimately result in
their association to blood vessels.3,19 Among these, FGF and
PDGF are the best established signaling pathways for this
role as mutations that alter pathway activation at any level
and result in reduced pericyte recruitment to blood vessels.
To test whether the motility response of healthy donor and
PAH pericytes occurs in response to these ligands, we used a
conventional Boyden chamber assay to measure pericyte
transmigration in response to 20 ng/mL PDGF or 10 ng/mL
FGF over 6 hours. While pericyte transmigration was more
robust in the healthy donor cells, PAH pericytes also
demonstrated a chemotactic response to both ligands
(Figure 3, A and B). This ﬁnding led us to speculate whetherFigure 2 Pulmonary arterial hypertension (PAH) pericytes (Pc) fail to associa
tube formation and demonstrate reduced polarization to the endothelial monolay
assays show tube formation by PMVEC (PKH67, green) alone (A) and in the pres
patients (C). Bottom row shows enlargements of the boxes in the top row. Note
healthy pericytes, whereas it appears clustered around nodes with PAH pericytes.
with PMVECs without and with pericytes from healthy subjects (control) or from P
PAH pericytes (PAH Pc) in the presence or absence of PMVECs. After 6 hours, peri
and eosin. The mean number of pericytes from four random 20 ﬁelds was used for
microtubule organization center, and of the wound-healing co-culture assay. G: R
are on the left and pericytes on the right. Bottom row shows enlargements of the
in circle at the bottom left of each panel indicates direction). The dashed lines in
cell movement. H: Quantiﬁcation of cell distance and percentage of polarized cel
*P < 0.05 versus PMVEC alone (one-way analysis of variance with Dunnett post-te
(E)] or versus control [Ctrl; unpaired t-test (H)]. Scale bars Z 100 mm.
The American Journal of Pathology - ajp.amjpathol.orgother candidate pathways could have a more pronounced role
in the recruitment of pericytes to pulmonary vessels.
Among possible candidate pathways, we prioritized the
Wnt/PCP pathway for a number of reasons. Originally
described in Drosophila, the Wnt/PCP pathway is involved
in coordinating directional cell movements during devel-
opment and orchestrating cell polarity across epithelial
surfaces.20 Wnt ligands interact with Fzd receptors in the
cell surface to trigger downstream activation of the small
GTPases RhoA, Rac1, and cdc42, which then coordinate the
cytoskeletal rearrangements necessary to affect cell move-
ment and polarization. Based on this information, we asked
whether Wnt/PCP signaling could be involved in steering
pericytes toward nascent pulmonary arteries.
As a ﬁrst step, we used the Boyden chamber approach to
measure the chemotactic response of healthy donor and PAH
pericytes to recombinant Wnt5a, a ligand known to activate
the Wnt/PCP pathway20 and known to be expressed in ECs,
where it helps to coordinate tight junction integrity and cell
polarity.21 Surprisingly, we found that 100 ng/mL recombi-
nant Wnt5a induced signiﬁcant translocation of healthy
pericytes across the Boyden membrane over a period of 6
hours. In contrast, PAH pericytes failed to demonstrate any
signiﬁcant motogenic response toWnt5a (Figure 3, A and B).
To measure Wnt/PCP activation in response to Wnt5a, we
stimulated healthy donor and PAH pericytes withWnt5a over
4 hours andmeasured levels of active RhoA, Rac1, and cdc42
in cell lysates. As anticipated, we found a signiﬁcant increase
in activity in all three GTPases in Wnt5a-stimulated healthy
donor cells, whereas no signiﬁcant activation was found in
PAH pericytes (Figure 3, C and D).
Expression of Wnt/PCP Components Fzd7 and cdc42 Is
Reduced in PAH Pericytes
We sought to characterize the expression proﬁle of all known
Wnt/PCP genes22 in both healthy donor and PAH pericytes
using TaqMan quantitative PCR and to determine whether
gene-expression patterns differed between the two groups.
Using this approach, we found the Wnt/PCP genes that were
either up-regulated or down-regulated (Figure 3E) in PAH
pericytes compared to healthy donor pericytes. The most
striking difference was found in the expression of Fzd7, ate with pulmonary microvascular endothelial cells (PMVECs) during vascular
er in both Boyden chamber and wound-healing co-culture assays. Matrigel
ence of pericytes (Pc) (PKH26, red) from healthy donors (B) or from PAH
that pericyte distribution is seen along the length of vascular tubes with
D: Numbers of tubes (left), branching points (middle), and loops (right)
AH patients. E: Boyden chamber comparing translocation of control Pc and
cytes at the bottom of the inserts were ﬁxed and stained with hematoxylin
comparison. F: Estimation of polarization using pericentrin, a marker of the
epresentative images of wound-healing co-culture assays in which PMVECs
boxes in the top row. Cell polarity was assessed by pericentrin (red section
dicate 0 hours; white lines, 6 hours. The arrowheads indicate directions of
ls after 6 hours. Data are expressed as means  SEM of three experiments.
st); ***P < 0.001 [one-way analysis of variance with Bonferroni post-test
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Figure 3 Reduced Wnt/planar cell polarity activation is present in PAH pericytes. Boyden chamber assays of pericytes from healthy donors (A) and PAH
patients (B), stimulated (black bars) with 20 ng/mL PDGF (top row), 10 ng/mL FGF (middle row), and 200 ng/mL Wnt5a (bottom row) over 6 hours. White
bars represent nonstimulated cells (control). C: Pull-down assays measuring active (a) forms of RhoA, cdc42, and Rac1 in lysates of Wnt5a-stimulated pericytes
from healthy donors (Pc) and PAH patients (PAH Pc) over a period of 4 hours. D: Densitometry values are shown as the ratios of the optical density of the
active form relative to the respective total GTPase in whole cell lysates that were run in C gels. The white bars represent no Wnt5a stimulation; black bars,
4-hour Wnt5a stimulation. E: TaqMan quantitative PCR for Wnt/PCP-related components in PAH pericytes. The expression of each gene is shown relative to that
in healthy pericytes. F: Representative Western immunoblot images of Fzd7 and cdc42 in whole lysates of pericytes from healthy donors (Ctrl) versus PAH
patients (PAH Pc). G: Densitometry values are shown as the ratio of the optical density of the active form relative to the respective total GTPase in whole cell
lysates. Blots were probed for total GTPase as a loading control. Data are expressed as means  SEM of three experiments. *P < 0.05, **P < 0.01, and
***P < 0.001 versus control [unpaired t-test (D), one-way analysis of variance with Bonferroni post-test (G)].
Yuan et almember of the Fzd family of seven-pass transmembrane re-
ceptors that binds Wnt ligands at the surface and activates
downstream mediators of the various Wnt pathways.23
Several studies have shown that Fzd7 is capable of acti-
vating the Wnt/PCP pathway to coordinate myogenic stem
cell motility24 as well as heart25 and body axis formation26 in
early mammalian development, and that its deﬁciency can
result in congenital disorders such as ventricular septal
defect.25 Western blot analysis of lysates from PAH pericytes
obtained after co-culture with PMVECs revealed a signiﬁcant
reduction in Fzd7 that correlated with low levels of active
RhoA, Rac1, and cdc42 activity as seen by pull-down assays
(Figure 3, F and G). Whereas levels of total RhoA and Rac1
were comparable between healthy and PAH pericytes, cdc42
expression was signiﬁcantly reduced in PAH.
To test whether Fzd7 deﬁciency could account for loss of
Wnt/PCP activation in PAH pericytes, we used siRNA to
knockdown Fzd7 expression in healthy pericytes to levels
comparable to those in PAH cells. Surprisingly, when co-78cultured in Matrigel with healthy PMVECs, we found that
Fzd7-deﬁcient pericytes were still capable of associating
with endothelial tubes in a manner comparable to that of
control siRNA-treated pericytes (Figure 4A), leading us to
question whether loss of Fzd7 alone is not sufﬁcient to
explain the PAH pericyte phenotype.
Knockdown of Both Fzd7 and cdc42 Suppresses
Pericyte Motility and Polarization
One of the most dramatic ﬁndings in our characterization of
PAH pericytes was their inability to properly polarize toward
the endothelium, as documented via LVM and wound-healing
assays. Among the downstream mediators of Wnt/PCP ac-
tivity, cdc42 is known to be essential for cell polarity as it can
help coordinate the proper location of actin ﬁlaments to steer
the cell in the right direction, and mutations that reduce either
level or activity of this small GTPase can result in severe de-
fects in cell polarization and motility.27,28 Furthermore, of theajp.amjpathol.org - The American Journal of Pathology
Figure 4 Knockdown of both Fzd7 and CDC42 in healthy pericytes shows impaired tube formation and cell polarity. A: Pericytes (Pc) were transfected with
nontargeting siRNA control (siCtrl), siFzd7, sicdc42, and siFzd7/cdc42 for 48 hours. Before seeded on Matrigel, cells were stained with PKHs. PMVEC were
stained in PKH67, green; Pc in PKH26, red; and DAPI in blue. The blue boxes indicate the enlarged areas of magniﬁcation in the bottom row. The white arrows
indicate the interaction of EC-Pc. Tube formations and the numbers of pericytes attached to the tubes were assessed after 6 hours. B: Polarity was also
assessed and measured on single or double knockout in healthy pericytes. The red arrowheads indicate directions of cell movement. C: Cell movement
distances and percentages of polarized cells were quantiﬁed when siFzd7/cdc42 were transfected on control pericytes. Data are expressed as means  SEM of
three experiments. *P < 0.05, **P < 0.01 versus control (unpaired t-test). Scale bars Z 100 mm.
ECePC Interactions in Lung Angiogenesisthree small GTPases targeted by Wnt/PCP, only cdc42
demonstrated reductions in both activity and total protein
levels in PAH cells (Figure 3, F and G). To test whether cdc42
deﬁciency could impair pericyte recruitment to endothelial
tubes, we used siRNA to knock down cdc42 in healthy peri-
cytes and performed co-culture studies with healthy PMVECs.
Similar to the Fzd7 siRNAetreated cells, the cdc42 siR-
NAetreated pericytes failed to recapitulate the phenotype of
PAH pericytes, as they also were capable of associating with
the endothelial tubes (Figure 4A).
One possible explanation for the lack of effect seen in either
Fzd7 or cdc42 siRNAetreated pericytes is the possibility of
compensation by other Fzd receptors present in the pericyte
membrane as well as parallel activation of other signaling
pathways (eg, PDGF29 and FGF30) involved in pericyte
recruitment to ECs that also target cdc42, thus compensating
for reduced Wnt/PCP signaling. To test this, we generated
Fzd7/cdc42 siRNA double-knockdown pericytes
(Supplemental Figure S2, A and B) and measured their ability
to associate with endothelial tubes in co-culture. In contrast to
either Fzd7 or cdc42 siRNAetreated cells, the ability of Fzd7-
or cdc42-deﬁcient pericytes to properly migrate and attach to
endothelial tubes was reduced by twofold, a ﬁnding that
closely recapitulated the behavior of PAH pericytesThe American Journal of Pathology - ajp.amjpathol.org(Figure 4A). We further tested the effect of Fzd7/cdc42
knockdown on pericyte polarization in response to PMVECs
using our modiﬁed wound-healing co-culture assay and
demonstrated that, similar to PAH pericytes, proper polariza-
tion of Fzd7- or cdc42-deﬁcient cells was decreased by 2.5-
fold and that movement to the endothelium was reduced by
2.8-fold (Figure 4, B and C).
Reduced Fzd7 and cdc42 Expression Prevents Pericyte
Association to Blood Vessels in SCID Mice
Our current studies indicate that dual Fzd7 and cdc42
depletion can impair pericyte motility and polarity toward
PMVECs and that PAH cells have decreased Fzd7 and
cdc42. However, whether this is relevant to in vivo estab-
lishment of endothelialepericyte interactions and their
failure in PAH is unknown. To study endothelialepericyte
behavior in vivo, we suspended co-cultures of PMVECs
with healthy pericytes transfected with either nontargeting
or Fzd7/cdc42 siRNA in Matrigel plugs and implanted
them on the backs of SCID mice for 14 days before
extraction, a well-established model for the study of in vivo
angiogenesis31 (see Materials and Methods). Compared to
PMVECs-only plugs (Figure 5A), co-cultures of PMVECs79
Figure 5 Reduction of Fzd7 and cdc42 prevents pericyte-induced microvessel formation in SCID mice. Representative images of hematoxylin and eosin
staining (AeD) and immunoﬂuorescence (EeH) show the appearance of PMVECs alone (A), PMVECs plus healthy pericytes (Pc) (B) as positive controls, PMVECs
plus healthy pericytes transfected with siRNA control (siCtrl) (C), and PMVECs plus healthy pericytes transfected simultaneously with siFzd7 and sicdc42 (D) 14
days after implantation into SCID mice. EeH: Human and murine CD31 is labeled with green ﬂuorescent antibodies, pericytes are labeled with a-SMA-Cy3 red
ﬂuorescent antibodies, and nuclei are stained blue with DAPI. Quantiﬁcation of vessel diameter (I) in micrometers and the percentage of pericyte coverage
(J). Data are expressed as means  SEM of three experiments. ***P < 0.001 versus PMVECs þ Pc siCtrl. Scale bar Z 25 mm.
Yuan et alwith pericytes transfected with nontargeting siRNA resul-
ted in blood-ﬁlled vessels with larger diameters (Figure 5C)
and complete mural coverage by pericytes, as evidenced by
positive a-SMA staining around the CD31-positive ECs
(Figure 5G). In contrast, plugs containing PMVECs and
Fzd7/cdc42 siRNAetreated pericytes (Figure 5D) con-
tained twofold smaller blood-ﬁlled vessels that were similar
in appearance to those in the PMVEC-only plugs (Figure 5,
A and I) and less than 2.6-fold pericyte coverage as80evidenced by minimal circumferential a-SMA staining
(Figure 5, H and J).
Restoration of Fzd7 and cdc42 Improves Establishment
of Endothelial-Pericyte Interactions by PAH Pericytes
in a Matrigel Co-Culture Model
To determine whether restoring Fzd7 and cdc42 expression
in PAH pericytes could increase Wnt/PCP activity andajp.amjpathol.org - The American Journal of Pathology
Figure 6 Transfection of Fzd7 and cdc42 expression constructs in PAH
pericytes improve their ability to associate with vascular tubes. A: PAH
pericytes were transfected with GFP-tagged Fzd7 and cdc42 plasmids (green)
and seeded with PMVECs (red) in Matrigel-coated plates (top row). Bottom
row shows enlargements of the boxes in the middle row. The white arrows
indicate the interaction of EC-Pc. B: Quantiﬁcation of total tube lengths in
micrometers (left), total number of branching points (middle), and numbers
of loops (right). Data are expressed as means  SEM of three experiments.
***P < 0.001 versus control (Ctrl-GFP). Scale bar Z 100 mm.
Figure 7 Model representing that Wnt/planar cell polarity signaling
ECePC Interactions in Lung Angiogenesisimprove their ability to associate with endothelial tubes, we
transfected plasmids containing wild-type Fzd7-GFP and
cdc42-GFP into PAH pericytes followed by co-culture with
healthy PMVECs in Matrigel. As anticipated, compared to
cells transfected with empty vector, Matrigel co-cultures of
PMVECs with wild-type Fzd7 þ cdc42etransfected PAH
pericytes demonstrated an increase in tube network size, as
evidenced by a signiﬁcant increase in the total length of
tubes, total branching points, and number of loops (Figure 6,
A and B). As anticipated, PAH pericytes were now able to
wrap around endothelial tubes and enhance PMVECs to
form wider tubes, as seen in co-culture studies with healthy
pericytes (Figure 2B).contributes to the association between pericytes and developing blood
vessels via the Wnt5a-Fzd7-cdc42 axis. The up-regulation of cdc42 on
Wnt5a/Fzd7 signaling results in increased motility and polarity, which in
turn results in healthy growth. A lack of Wnt5a/Fzd7 signaling results in
less motility and polarity, which in turn leads to a loss or reduction of the
interaction between endothelial cells (EC) and pericytes (Pc) and eventually
a loss of arteries, leading to PAH.Discussion
Until recently, most of our understanding of lung pericyte
distribution came from the study by Weibel,32 whichThe American Journal of Pathology - ajp.amjpathol.orgreported sparse distribution of these cells mainly along the
perialveolar capillaries and venules. In 2014, investigators
reported that pericyte numbers appeared to be increased in
the pulmonary microcirculation of PAH patients and that
this pattern appeared to correlate with muscularization of
distal vessels.11 The link between pericytes and small vessel
muscularization in PAH has been proposed by investigators
looking at lung sections of PAH patients with congenital
heart conditions33 as well as in transgenic murine models of
SM22a-mediated BMPR1A deletion.34 Our present study
provides new insight into the biology of these enigmatic
cells and their possible contribution to the progressive loss
of small pulmonary arteries seen in PAH. We also introduce
a key role for the Wnt/PCP signaling pathway in helping
pericytes to associate with developing blood vessels and
identify two key genes within this pathway whose reduced
expression severely impairs the ability of PAH pericytes to
provide mural coverage (Figure 7).81
Yuan et alThe major shortcoming of pericyte-isolation techniques is
the presence of contaminating cell populations and the
inability to distinguish pericyte phenotype from other
contaminating cells. Our approach to isolate pericytes from
lung tissue using modiﬁed antie3G5 IgG antibodies con-
jugated to magnetic beads was modiﬁed from a previously
published protocol.13 We found that this chimeric antibody:
i) has a longer (>3 months) shelf life, ii) has reliable per-
formance, and iii) is compatible with a wide range of ap-
plications. To conﬁrm the pericyte lineage of the lung cells
isolated using the chimeric 3G5 IgG, we used ﬂuorescence-
activated cell sorting to document the expression of a wide
range of lineage markers known to be expressed by peri-
cytes. In our study, 10 ﬂuorophore conjugated antibodies
were stained simultaneously on a single cell. However, we
must recognize that this is still a narrow selection of markers
and that there are more pericyte markers that need to be
further evaluated, such as inter-cellular adhesion molecule,
Nestin, regulator of G-protein signaling 5, vascular cell
adhesion molecule 1, Vimentin, which will be the subject of
our future studies.17 Our study is also limited in that we did
not look for dedifferentiated cells in our population, an issue
that could be relevant especially when we consider that
pericytes have been suggested by some investigators to
behave as pluripotent and mesenchymal-like cells in some
settings.3 Future studies should look carefully at the effects
of culture condition, cell density, and signaling factors that
could inﬂuence the potential of the pericytes to change into
other cell types under various cell-culture conditions.
One of the most striking ﬁndings in this study is the limited
association of PAH pericytes with vascular tubes seen in the
Matrigel co-culture assays. Use of co-culture methods has
remained a viable and useful strategy to study endothelial-
pericyte interactions in vitro as it provides not only the op-
portunity to study signaling pathways but also to visually
capture the behavior of both cell types in real time.19,35e37
Furthermore, vascular networks assembled in co-culture
models have greater longevity compared to those made by
ECs alone.19,36 Although the use of the Matrigel matrix for the
study of angiogenesis is well documented, it is important to
point out that its protein composition and growth factor con-
tent15 may be signiﬁcantly different from what is found in the
lung and could inﬂuence the cell behavior in co-culture.
However, it is pertinent to mention that we were able to
reproduce the behavior of PAH pericytes when cultured in
collagen,36 hydrogel,38 and ﬁbrin39 based matrices (data not
shown), leading us to conclude that the phenotype observed in
our Matrigel studies is an inherent feature of these cells. These
ﬁndings are relevant in light of the recent report stating an
increase in pericyte numbers in the pulmonary microcircula-
tion of PAH patients.11 Although this study supports the
presence of pericyte-like cells around the vessels, it is unclear
to what extent these cells are in direct physical contact with the
ECs within these vessels. This is clinically relevant as a lack of
physical contact could reduce vessel viability and result in
small vessel loss, a pertinent pathological feature of PAH.40,4182The use of LVM and wound-healing assays provided
important information concerning the behavior of pericytes
during the assembly of vascular networks and led us to
identify a defect in both motility and polarity in PAH peri-
cytes. Cell motility is a highly dynamic cellular event that
requires the relocation and assembly of cytoskeletal com-
ponents and is tightly controlled by the temporal activation of
small GTPases such as RhoA, Rac1, and cdc42.27 We found
that, in contrast to healthy cells, PAH pericytes appeared to
move slower and demonstrate persistence in their attachment
to a given region of the culture plate (Supplemental
Figure S1). In addition, it was also evident that most of the
PAH pericytes could not generate wide lamellipodia, a
structure that assists cell motility by helping to provide for-
ward traction to the front end of the cell and whose absence is
known to compromise the speed, distance, and persistence of
cell movement.42 This observation is in contrast with reports
of increased PAH pericyte motility when exposed to endo-
thelial conditioned media.11 However, it is worth pointing
out that we always used healthy PMVECs in all of the co-
culture assays and the production of mediators from these
cells is open to the inﬂuence of mediators produced by per-
icytes, a situation that was developed to recapitulate the way
these two cell types are thought to interact during angio-
genesis. This is particularly relevant when we consider that
co-culture studies of healthy pericytes with PAH PMVECs
also demonstrated an impairment of pericyte association with
vascular tubes (data not shown), thus supporting a crucial
role for the ECs in driving recruitment of pericytes.
Signaling cascades between pericytes and ECs have been
studied extensively using genetic mouse models. To point out
a few: i) PDGFb/PDGFRb signaling mediates pericyte
recruitment,43 ii) transforming growth factor b signaling has
been implicated in bothmural and EC differentiation,44 and iii)
angiopoietin-1/Tie-2 paracrine loop reciprocally mediates
pericyteeEC interaction and stability.45 However, the role of
the Wnt signaling pathways remain poorly characterized
despite evidence that these pathways are crucial for pulmonary
angiogenesis. We previously reported that bone morphoge-
netic protein 2 (BMP2), via BMP receptor 2 (BMPR2), in-
duces b-catenin activation, which is essential for pulmonary
artery EC survival and proliferation, whereas the activation of
RhoA-Rac1 signaling is necessary for motility.31 The latter
represents the ﬁrst evidence of Wnt/PCP recruitment in the
pulmonary circulation and led us to postulate that this pathway
could also be involved in coordinating pericyte motility and
polarity.46 In our model, PAH pericytes had impaired motility
and polarity both at baseline and in the presence of PMVECs,
and their response to Wnt5a stimulation was signiﬁcantly less
compared to that of control cells, which argues strongly for a
defect in the ability of PAHpericytes to activate theirWnt/PCP
pathway. Furthermore, given the ability of the Wnt pathways
to cross-talk with BMP signaling, it may be of interest to
determine whether this interaction is also present in pericytes
and whether BMPR2 mutations can inﬂuence Wnt/PCP acti-
vation in PAH pericytes.ajp.amjpathol.org - The American Journal of Pathology
ECePC Interactions in Lung AngiogenesisAn important observation was that the ability of pericytes
to associate with PMVECs was signiﬁcantly impaired when
both Fzd7 and cdc42 were simultaneously reduced. We
speculate that this may be due to the presence of redundant
receptors or signaling pathways that compensate when one
of these two genes is impaired but fail to do so when both
become deﬁcient. Evidence to support our model comes
from the fact that there are 10 known Fzd receptors47 and
they are expressed in healthy pericytes in various pro-
portions, thus allowing the possibility that any of these
could compensate for Fzd7 loss and preserve Wnt/PCP
activation. Furthermore, other pathways known to attract
pericytes to blood vessels (eg, PDGF, FGF2) can also target
cdc42 independently and may help with its activation when
Fzd7 becomes deﬁcient. The small GTPase cdc42 has been
shown to be essential for vasculogenesis during embryonic
development, and its deletion reduces survival and migra-
tion of ECs.48 However, the fact that pericytes deﬁcient in
both Fzd7 and cdc42 lose their ability to interact with ECs
in co-culture supports a model in which these two genes
work within a vital signaling network that may not be
restored by cross-talk with other pathways.
In conclusion, this is the ﬁrst report of a defect in pericyte
motility contributing to the pathobiology of PAH and of a
novel role for Wnt/PCP in pericyte recruitment and estab-
lishment of endothelial-pericyte contacts. This is relevant as
a loss of peripheral pulmonary arteries and impaired
regeneration of normal vessels are key pathological features
of PAH. As a modiﬁer of BMP signaling in endothelial and
smooth muscle cells,31,49 Wnt/PCP signaling is a strong
candidate to understand how pulmonary angiogenesis is
orchestrated. Understanding how Wnt/PCP participates in
pulmonary angiogenesis will provide a new paradigm to
understand how pulmonary vessels can regenerate after
injury and should provide new avenues for therapeutic
interventions aimed at reversing the progression of PAH.
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